Cargando…

Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines

Antiplatelet therapy, mainly consisting of aspirin and P2Y(12) receptor antagonists, is the cornerstone of the pharmacological treatment and prevention of atherothrombotic diseases. Its use, especially in secondary cardiovascular prevention, has significantly improved patient clinical outcomes in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jourdi, Georges, Marquis-Gravel, Guillaume, Martin, Anne-Céline, Lordkipanidzé, Marie, Godier, Anne, Gaussem, Pascale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092185/ https://www.ncbi.nlm.nih.gov/pubmed/35571090 http://dx.doi.org/10.3389/fphar.2022.878416

Ejemplares similares

Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches
por: Jourdi, Georges, et al.
Publicado: (2022)

Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases
por: Jourdi, Georges, et al.
Publicado: (2021)

Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada
por: Lordkipanidzé, Marie, et al.
Publicado: (2020)

Antiplatelet combinations for prevention of atherothrombotic events
por: Bollati, Mario, et al.
Publicado: (2011)

Novel Antiplatelet Therapies for Atherothrombotic Diseases
por: Majithia, Arjun, et al.
Publicado: (2019)

Medicinal Herbals with Antiplatelet Properties Benefit in Coronary Atherothrombotic Diseases
por: Mohd Nor, Nurul Huda, et al.
Publicado: (2016)

Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options
por: Fintel, Dan J
Publicado: (2012)

Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: what is the evidence?
por: Jourdi, Georges, et al.
Publicado: (2023)

Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report
por: Godier, Anne, et al.
Publicado: (2018)

Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome
por: Carré, Julie, et al.
Publicado: (2021)

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
por: Ekholm, M., et al.
Publicado: (2021)

Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls
por: Godier, Anne, et al.
Publicado: (2020)

Comparative In Vitro Study of Various α(2)-Adrenoreceptor Agonist Drugs for Ticagrelor Reversal
por: Porta Bonete, Guillaume, et al.
Publicado: (2020)

Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy
por: Balasubramaniam, Karthik, et al.
Publicado: (2012)

Bothrops atrox and Bothrops lanceolatus Venoms In Vitro Investigation: Composition, Procoagulant Effects, Co-Factor Dependency, and Correction Using Antivenoms
por: Larréché, Sébastien, et al.
Publicado: (2023)

Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk
por: Murphy, Andrew J., et al.
Publicado: (2022)

Unexplored Roles of Erythrocytes in Atherothrombotic Stroke
por: Papadopoulos, Charalampos, et al.
Publicado: (2023)

PCSK9 as an Atherothrombotic Risk Factor
por: Sotler, Tadeja, et al.
Publicado: (2023)

Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis
por: Bainey, Kevin R., et al.
Publicado: (2023)

No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19
por: Petrazzuolo, Adriana, et al.
Publicado: (2020)

Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles
por: Giacomazzi, Alice, et al.
Publicado: (2016)

Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study
por: Reuwer, Anne Q., et al.
Publicado: (2011)

Environmental noise exposure is associated with atherothrombotic risk
por: Koczorowski, Magali, et al.
Publicado: (2022)

Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases
por: Petrucci, Giovanna, et al.
Publicado: (2022)

Antiplatelet and Antithrombotic Activity of a Traditional Medicine, Hwangryunhaedok-Tang
por: Kim, Kyungho, et al.
Publicado: (2019)

Plant Alkaloids as Antiplatelet Agent: Drugs of the Future in the Light of Recent Developments
por: Ain, Qurrat-Ul-, et al.
Publicado: (2016)

Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?
por: Taus, Francesco, et al.
Publicado: (2019)

The Role of Biomarkers in Atherothrombotic Stroke—A Systematic Review
por: Andone, Sebastian, et al.
Publicado: (2021)

Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk
por: Mauriello, Alfredo, et al.
Publicado: (2023)

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease
por: Wawruch, Martin, et al.
Publicado: (2021)

Phospholipase Cγ2 Signaling Cascade Contribute to the Antiplatelet Effect of Notoginsenoside Fc
por: Liu, Yingqiu, et al.
Publicado: (2018)

Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria
por: Hannachi, Nadji, et al.
Publicado: (2020)

Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process
por: Nocella, Cristina, et al.
Publicado: (2021)

A New Score for Predicting Acute Gastrointestinal Bleeding in Patients Administered Oral Antiplatelet Drugs
por: Lv, Meina, et al.
Publicado: (2021)

Plasma levels of platelet-enriched microRNAs change during antiplatelet therapy in healthy subjects
por: Krammer, Teresa L., et al.
Publicado: (2022)

The EAG Voltage-Dependent K(+) Channel Subfamily: Similarities and Differences in Structural Organization and Gating
por: Barros, Francisco, et al.
Publicado: (2020)

Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery Disease
por: Petersen-Uribe, Álvaro, et al.
Publicado: (2021)

A Novel Antiplatelet Aggregation Target of Justicidin B Obtained From Rostellularia Procumbens (L.) Nees
por: Yang, Yan-Fang, et al.
Publicado: (2019)

Efficacy of a Combined Antiplatelet Therapy Is Not Affected by a Simultaneous Binding of Cangrelor and PSB 0777 to Albumin
por: Wzorek, Joanna, et al.
Publicado: (2021)

Incidence and impact of antiplatelet therapy cessation among very older patients with stable coronary artery disease
por: Zou, Xiao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_foug4r653sf1u1i6rb00uu5gbt